Podchaser Logo
Home
Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients

Released Tuesday, 12th December 2023
Good episode? Give it some love!
Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients

Tuesday, 12th December 2023
Good episode? Give it some love!
Rate Episode

Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function.



Hosted on Acast. See acast.com/privacy for more information.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features